Why Syndax Pharmaceuticals Stock Is Sinking Today

Why Syndax Pharmaceuticals Stock Is Sinking Today
Keith Speights, The Motley Fool
·2 min read

Shares of Syndax Pharmaceuticals (NASDAQ: SNDX) were sinking 28% as of 11:32 a.m. EDT on Tuesday. This big decline came after the company reported positive results from a phase 1 study evaluating SNDX-5613 in treating leukemia. The company reported a 48% overall response rate in patients with mixed lineage leukemia-rearranged (MLLr) and nucleophosmin (NPM1c) mutant relapsed/refractory (R/R) acute leukemias.